Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cardiovascular Research

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0008-6363(02)00723-XPMID 12618236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat.

  2002cited by this paper
• Increased Myocardial Gene Expression of Tumor Necrosis Factor-&agr; and Nitric Oxide Synthase-2: A Potential Mechanism for Depressed Myocardial Function in Hibernating Myocardium in Humans

  2002cited by this paper
• Load-Dependent and -Independent Regulation of Proinflammatory Cytokine and Cytokine Receptor Gene Expression in the Adult Mammalian Heart

  2002cited by this paper
• Angiotensin II Induces Tumor Necrosis Factor Biosynthesis in the Adult Mammalian Heart Through a Protein Kinase C-Dependent Pathway

  2002cited by this paper
• Subacute and Chronic Effects of Quinapril on Cardiac Cytokine Expression, Remodeling, and Function After Myocardial Infarction in the Rat

  2002cited by this paper
• Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

  2002cited by this paper
• Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support.

  2002cited by this paper
• Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats.

  2001cited by this paper
• Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors.

  2001cited by this paper
• Nuclear factor kappa-B and the heart.

  2001cited by this paper
• Role of TLR-2 in the Activation of Nuclear Factor κB by Oxidative Stress in Cardiac Myocytes*

  2001cited by this paper
• Improvement of Left Ventricular Remodeling and Function by Hydroxymethylglutaryl Coenzyme A Reductase Inhibition With Cerivastatin in Rats With Heart Failure After Myocardial Infarction

  2001cited by this paper
• Systemic Infusion of Angiotensin II into Normal Rats Activates Nuclear Factor-κB and AP-1 in the Kidney : Role of AT1 and AT2 Receptors

  2001cited by this paper
• Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

  2000cited by this paper
• Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium.

  1999cited by this paper
• An essential role for NF-kappaB in the cardioadaptive response to ischemia.

  1999cited by this paper
• Activators and target genes of Rel/NF-κB transcription factors

  1999cited by this paper
• Activators and target genes of Rel/NF-kappaB transcription factors.

  1999cited by this paper
• The Rel/NF-κB signal transduction pathway: introduction

  1999cited by this paper
• An essential role for NF-κB in the cardioadaptive response to ischemia

  1999cited by this paper
• Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.

  1999cited by this paper
• Bridging the Gap: Composition, Regulation, and Physiological Function of the IκB Kinase Complex

  1999cited by this paper
• The Rel/NF-kappaB signal transduction pathway: introduction.

  1999cited by this paper
• Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy.

  1999cited by this paper
• Nuclear factor NF-κB in myocardium: developmental expression of subunits and activation by interleukin-1β in cardiac myocytes in vitro

  1998cited by this paper
• Nuclear factor NF-kappa B in myocardium: developmental expression of subunits and activation by interleukin-1 beta in cardiac myocytes in vitro.

  1998cited by this paper
• Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.

  1998cited by this paper
• Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling.

  1998cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998cited by this paper
• Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats.

  1998cited by this paper
• Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure.

  1998cited by this paper
• In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

  1997cited by this paper
• Induction of nuclear factor κB and activation protein 1 in postischemic myocardium

  1997cited by this paper
• Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.

  1997cited by this paper
• NF-kappa B: ten years after.

  1996cited by this paper
• NF-κB: Ten Years After

  1996cited by this paper
• The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*)

  1995cited by this paper
• Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

  1986cited by this paper
• Nuclear Factor- (cid:107) B Plays an Essential Role in the Late Phase of Ischemic Preconditioning in Conscious Rabbits

  year unknowncited by this paper

• Implications of Oxidative Stress in the Pathophysiological Pathways of Heart Failure

  2025cites this paper
• Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosis

  2024cites this paper
• Interaction between cardiac resynchronization therapy and cytokines in heart failure patients.

  2024cites this paper
• Promising Therapeutic Treatments for Cardiac Fibrosis: Herbal Plants and Their Extracts

  2023cites this paper
• System pharmacology-based determination of the functional components and mechanisms in chronic heart failure treatment: an example of Zhenwu decoction

  2023cites this paper
• Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics

  2023cites this paper
• Endoplasmic reticulum stress-activated nuclear factor-kappa B signaling pathway induces the upregulation of cardiomyocyte dopamine D1 receptor in heart failure.

  2022cites this paper
• Exploring the Impact of ACE Inhibition in Immunity and Disease

  2022cites this paper
• Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis

  2021cites this paper
• Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats

  2021cites this paper
• Diet-Derived Advanced Glycation End Products (dAGEs) Induce Proinflammatory Cytokine Expression in Cardiac and Renal Tissues of Experimental Mice: Protective Effect of Curcumin

  2021cites this paper
• Identification of Potential Biomarkers Associated with Acute Myocardial Infarction by Weighted Gene Coexpression Network Analysis

  2021cites this paper
• Fosl1 is vital to heart regeneration upon apex resection in adult Xenopus tropicalis

  2021cites this paper
• Sex-Specific Human Cardiomyocyte Gene Regulation in Left Ventricular Pressure Overload.

  2020cites this paper
• The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure

  2020cites this paper
• Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats

  2020cites this paper
• Molecular mediators, characterization of signaling pathways with descriptions of cellular distinctions in pathophysiology of cardiac hypertrophy and molecular changes underlying a transition to heart failure

  2019cites this paper
• New applications of oleanolic acid and its derivatives as cardioprotective agents: A review of their therapeutic perspectives.

  2019cites this paper
• Metabolomics for Biomarker Discovery in Fermented Black Garlic and Potential Bioprotective Responses against Cardiovascular Diseases.

  2019cites this paper
• Vitamin D downregulates key genes of diabetes complications in cardiomyocyte

  2019cites this paper
• Endothelial TFEB (Transcription Factor EB) Restrains IKK (I&kgr;B Kinase)-p65 Pathway to Attenuate Vascular Inflammation in Diabetic db/db Mice

  2019cites this paper
• Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1β in heart failure.

  2019cites this paper
• Correction: Antihypertensive Effect of Polyphenol-Rich Fraction of Azadirachta indica on Nω-Nitro-L-Arginine Methyl Ester-Induced Hypertension and Cardiorenal Dysfunction

  2018cites this paper
• Oxidative Stress and Cardiac Remodeling: An Updated Edge

  2018cites this paper
• Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function.

  2018cites this paper
• Inflammation in Right Ventricular Failure: Does It Matter?

  2018cites this paper
• Antihypertensive Effect of Polyphenol-Rich Fraction of Azadirachta indica on Nω-Nitro-L-Arginine Methyl Ester-Induced Hypertension and Cardiorenal Dysfunction

  2018cites this paper
• Oxidative stress and inflammation: new molecular targets for cardiovascular diseases

  2018cites this paper
• Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction

  2018cites this paper
• A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction

  2017cites this paper
• Thyroid hormones decrease the proinflammatory TLR4/NF-κβ pathway and improve functional parameters of the left ventricle of infarcted rats.

  2017cites this paper
• Dieldrin Augments mTOR Signaling and Regulates Genes Associated with Cardiovascular Disease in the Adult Zebrafish Heart (Danio rerio)

  2017cites this paper
• Paying for the Tolls: The High Cost of the Innate Immune System for the Cardiac Myocyte.

  2017cites this paper
• Knockout of the ATPase inhibitory factor 1 protects the heart from pressure overload-induced cardiac hypertrophy

  2017cites this paper
• Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets

  2017cites this paper
• Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

  2017cites this paper
• Improvement of Left Ventricular Remodelling by Inhibition of NF-κB in a Rat Model of Myocardial Infarction.

  2016cites this paper
• AMP-activated protein kinase α1-sensitive activation of AP-1 in cardiomyocytes.

  2016cites this paper
• THE ROLE OF CYTOCHROME P450 AND THEIR ASSOCIATED ARACHIDONIC ACID METABOLITES IN THE INITIATION AND PROGRESSION OF CARDIAC HYPERTROPHY

  2016cites this paper
• CYP2J2 Overexpression Increases EETs and Protects Against HFD-Induced Atherosclerosis in ApoE−/− Mice

  2016cites this paper
• Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a.

  2016cites this paper
• Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.

  2015cites this paper
• Chronic electroacupuncture of the ST36 point improves baroreflex function and haemodynamic parameters in heart failure rats.

  2015cites this paper
• Angiotensin II-superoxide-NFκB signaling and aortic baroreceptor dysfunction in chronic heart failure

  2015cites this paper
• Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure

  2015cites this paper
• CARDIOPROTECTIVE EFFECT OF PERSEA AMERICANA MILL FRUIT EXTRACT IN EXPERIMENTAL MYOCARDIAL INFARCTION

  2015cites this paper
• Oxysophoridine attenuates the injury caused by acute myocardial infarction in rats through anti-oxidative, anti-inflammatory and anti-apoptotic pathways.

  2015cites this paper
• The role of transcription factors in the formation of an arrhythmogenic substrate in congestive human heart failure.

  2014cites this paper
• In Vivo Transfection of Manganese Superoxide Dismutase Gene or Nuclear Factor &kgr;B shRNA in Nodose Ganglia Improves Aortic Baroreceptor Function in Heart Failure Rats

  2014cites this paper
• Recombinant adeno-associated virus serotype 9 with p65 ribozyme protects H9c2 cells from oxidative stress through inhibiting NF-κB signaling pathway

  2014cites this paper
• Genetically altered mutant mouse models of guanylyl cyclase/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner.

  2014cites this paper
• Huperzine A ameliorates damage induced by acute myocardial infarction in rats through antioxidant, anti-apoptotic and anti-inflammatory mechanisms.

  2014cites this paper
• Efficacy of Female Rat Models in Translational Cardiovascular Aging Research

  2014cites this paper
• Citrate Synthase Is a Novel In Vivo Matrix Metalloproteinase-9 Substrate That Regulates Mitochondrial Function in the Postmyocardial Infarction Left Ventricle

  2014cites this paper
• Enhanced expression of Gqα and PLC-β1 proteins contributes to vascular smooth muscle cell hypertrophy in SHR: role of endogenous angiotensin II and endothelin-1.

  2014cites this paper
• Genetic predisposition to left ventricular dysfunction: a multigenic and multi-analytical approach.

  2014cites this paper
• Gene Profiling, Energy Metabolism, and Remodeling of the Failing Heart

  2014cites this paper
• Dynamic reorganization of the AC16 cardiomyocyte transcriptome in response to TNFα signaling revealed by integrated genomic analyses

  2014cites this paper
• Role of inflammatory gene polymorphisms in left ventricular dysfunction (LVD) susceptibility in coronary artery disease (CAD) patients.

  2013cites this paper
• Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction.

  2013cites this paper
• Re-analysis of expression profiles for revealing new potential candidate genes of heart failure.

  2013cites this paper
• [Techniques for assaying the activity of transcription factor NF-κB].

  2013cites this paper
• Myocardial infarction induces sympathetic hyperinnervation via a nuclear factor-κB-dependent pathway in rabbit hearts.

  2013cites this paper
• Biophysics of Membrane Currents in Heart Failure

  2013cites this paper
• Chlorogenic acid attenuates ventricular remodeling after myocardial infarction in mice.

  2013cites this paper
• Coconut kernel protein in diet protects the heart by beneficially modulating endothelial nitric oxide synthase, tumor necrosis factor-alpha, and nuclear factor-kappaB expressions in experimental myocardial infarction

  2013cites this paper
• Cardioprotective effects of the YiQiFuMai injection and isolated compounds on attenuating chronic heart failure via NF-κB inactivation and cytokine suppression.

  2013influential citation
• The pathological roles of environmental and redox stresses in cardiovascular diseases

  2013cites this paper
• The function of miRNA in cardiac hypertrophy

  2012cites this paper
• Cardiovascular , Pulmonary , and Renal Pathology The NF-B Subunit c-Rel Stimulates Cardiac Hypertrophy and Fibrosis

  2012cites this paper
• Reactive oxygen species signaling in cardiac remodeling and failure

  2012cites this paper
• Inhibition of IκB phosphorylation prevents load-induced cardiac dysfunction in mice.

  2012cites this paper
• Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy

  2012cites this paper
• Role of NF-κB and p38 MAPK activation in mediating angiotensin II and endothelin-1-induced stimulation in leptin production and cardiomyocyte hypertrophy

  2012cites this paper
• Molecular Basis of Abnormal Conduction in Mice Over-expressing Endothelin-1

  2012cites this paper
• expression: implications for cardiorenal syndrome renal interstitial fibrosis, and increases renal KIM-1 Myocardial infarction impairs renal function, induces

  2012cites this paper
• OPG/RANK/RANKL Axis in Stabilization of Spontaneously Restored Sinus Rhythm in Permanent Atrial Fibrillation Patients after Mitral Valve Surgery

  2012cites this paper
• Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome.

  2012cites this paper
• The NF-κB subunit c-Rel stimulates cardiac hypertrophy and fibrosis.

  2012cites this paper
• MicroRNA Involvement in Immune Activation During Heart Failure

  2011cites this paper
• Intramyocardial administration of chimeric ephrinA1‐Fc promotes tissue salvage following myocardial infarction in mice

  2011cites this paper
• Therapeutic targeting of innate immunity in the failing heart.

  2011cites this paper
• Identification of a novel aldose reductase-like gene upregulated in the failing heart of cardiomyopathic hamster

  2011cites this paper
• Nuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling.

  2011cites this paper
• MicroRNA-24 Regulates Vascularity After Myocardial Infarction

  2011cites this paper
• Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control.

  2011cites this paper
• MicroRNAs as Effectors for Acetyltransferase p300 in Cardiac Hypertrophy

  2011cites this paper
• Toll-like receptors as potential therapeutic targets in cardiac dysfunction

  2011cites this paper
• Can molecules released from skeletal muscle influence the heart? the effect of fibre type and HSP content

  2011cites this paper
• To kill two birds with one stone: a pleurocentesis that also drained pericardial tamponade in a stubbed patient.

  2011cites this paper
• Identify potential chronic heart failure related transcription factors by network analysis

  2011cites this paper
• Frontiers in Research Series: Neural, Hormonal and Renal Interactions in Long-term Blood Pressure Control II Regulation of cardiac angiotensin-converting enzyme and angiotensin AT1 receptor gene expression in Npr1 gene-disrupted mice

  2010cites this paper
• Modulation of the reaction of vascular smooth muscle cells to angiotensin II induced by catalase and aminotriasol during ischemia-reperfusion.

  2010cites this paper
• Regulation of heat shock protein 60 and 72 expression in the failing heart.

  2010cites this paper
• Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons.

  2010cites this paper
• AFos inhibits phenylephrine-mediated contractile dysfunction by altering phospholamban phosphorylation.

  2010cites this paper
• HMGB1: the missing link between diabetes mellitus and heart failure

  2010cites this paper
• Gene silencing of myofibrillogenesis regulator-1 by adenovirus-delivered small interfering RNA suppresses cardiac hypertrophy induced by angiotensin II in mice.

  2010cites this paper
• Innate immunity and remodelling

  2010cites this paper
• What causes a broken heart--molecular insights into heart failure.

  2010cites this paper